SUMMARY Seventeen infants with severe (14) or moderately severe (3) erythroblastosis were given daily oral supplements of 2 5 or 5 mg folic acid from day 16 (average) to 3*2 months (average). Their rate of weight gain, expressed as weight centiles, was followed for 1 year and was compared with that of a very similar group of 34 erythroblastotic infants without folic acid supplements. By the end of the 4th month, just after stopping additional folate intake, the median centiles for weight had risen from the 40th to the 80th centile, while in the untreated control group they rose during this period from the 35th to the 50th centile. During the second half of the year both groups declined in weight centiles, the 'treated' group ending up at the 50th centile for weight, while the control group fell to the 25th.
In the preceding papers (parts I and II, pp. 1, 7) it was shown that erythroblastotic infants have a slightly lower birthweight than well-matched controls, and that mothers with low serum folate (<5 ,ug/l) gave birth to 4 times as many small-fordates infants as mothers whose serum folate was 8 ,ug/l or more. The growth pattern of the erythroblastotic infants over the first year showed an initial period of accelerated weight gain, but during the second half of the year the growth rate was slower than expected and about one-third ended up below their birth centile for weight at the end of the first year; furthermore, there were twice the number of infants at or below the 10th centile than would be expected (11 out of 55 infants). There was a significant correlation between rising weight centiles and serum folate levels of 8 ,ug/l or more; falling weight centiles were associated with serum folate values of less than 5 ,tg/l.
Data are now presented to show the beneficial effect on growth when folic acid was given to an unselected group of erythroblastotic infants.
Patients
A group of 17 infants with erythroblastosis were randomly selected for folic acid supplementation Received 5 April 1976 *Sir Halley Stewart Research Fellow (2 5-5 mg/d by mouth); this was usually started after the first week (average age 16 days) and continued for about 3 months. All except 3 of the 17 infants were classified as severely affected in that they required either exchange transfusions (6 cases), or subsequent 'top-up' transfusions (4 cases), or both (4 cases). The remaining 3 infants were classified as moderately affected in that their Hb levels fell below 10 g/dl during the first 3 weeks of life though no transfusion was required.
The control group consisted of 34 infants taken from the series described in part II. 25 were severely affected and 9 moderately so. The controls were selected to match the folic acid treated group as far as possible (Table 1) .
Attempts were made to collect umbilical cord blood for Hb and serum folate at delivery, and further blood samples at appropriate intervals, especially before and after folate supplementation. Exchange and subsequent 'top-up' transfusions were performed as clinically indicated. 16 of the 17 infants in the folic acid treated group were followed for one year, as were about 80% of the control group (27 of 34). When blood was taken by venepuncture for Hb determination, a sample was usually obtained for serum folate.
The weights of the infants at birth and subsequently were converted into weight centiles as described in parts I and II, due allowance being made for gestational age. The Lactobacillus casei assay for 16 the controls during this period, the differences were not significant.
Although 3 of 17 infants in the treated group had been at or below the 10th centile for weight at birth, after stopping folate supplements (i.e. by the 4th month) none stayed at such a low centile throughout the remainder of the year. In the control group 6 of 34 infants were at or below the 10th centile at birth and by the end of the year 6 out of 27 were still at this low value.
Serum folate ( Table 3) . The treated and control groups had similar values at birth and shortly thereafter. At the end of the treatment (at about 4 months) the average serum folate of the treated group had risen to 35 7 ,ug/l and none had a level <8 ,ug/l. The control group at this time had an average of 7 ,ug/l (median 4 6) and over half the infants had <5 ,tg/l (Table 3) . During the 6th to 8th month, after stopping treatment when only 7 of the infants had blood taken for serum folate, the average value had dropped to normal levels, though none had 5 ,ug or less, while one-third of the control group had <5 ,ug/l. By the end of the year both groups had similar levels of serum folate, with 3 out of 8 previously treated infants having <5 ,ag/l. Similarly, 5 out of 17 control infants of whom serum folate values were available had <5 ,g/l towards the end of the year. As could be expected, the infants who had received folate supplements 6 to 8 months previously no longer showed any changes in serum folate levels by the end of the year, when compared with the control groups.
Haemoglobin levels ( Table 4 ). The average Hb of the treated and the control groups was not significantly different at birth or during the first and second half of the year. No effect on the level of Hb was demonstrable in the folic acid treated group.
Discussion
In parts I and II of this study (pp. 1, 7) it was shown that erythroblastotic infants have a lower average birthweight than carefully matched controls. During the first 6 months after birth the erythroblastotic infants gained weight at a slightly greater rate than would be predicted from standard growth charts, but during the second half of the year about one-third of the infants failed to maintain their expected growth rate as shown by a declining centile for weight. Furthermore, it was suggested that a maternal shortage of folic acid might play a role in the lower average birthweight and that a shortage of folate in the infant later on might lead to a reduction in growth rate. There was a significant correlation between declining centiles for weight and low levels of serum folate (<5 t,g/l). Maintenance of weight centiles was usually associated with satisfactory serum folate levels (>8 ,ug!l).
This pilot study was undertaken in order to ascertain whether folic acid supplementation given for a limited period of time would have a beneficial effect on the rate of weight gain (expressed as centiles for weight) in a small group of erythroblastotic infants who, though anaemic, showed no signs of a shortage of folic acid other than a frequently low serum folate and a deficit in weight centile rating, particularly during the second half of the year.
In the present study 34 erythroblastotic infants served as controls, 25 were severely and 9 moderately severely affected. The folic acid supplemented group of 17 consisted of 14 with severe and only 3 with moderately severe disease. Neither group included mildly affected infants. Thus, if there is any bias in the composition of the treated and the control group it would be in favour of the control group, because moderately affected infants show a slightly faster growth rate during the first half of the year than severely affected ones (see part II).
The result of folic acid supplementation for about 3 months showed that the 17 infants improved their weight centiles during this period to a significant degree, such that the group rose from an average of 40 at birth to 70 with a median value of 80, i.e. half of them were at or above the 80th centile, and none were at or below the 10th centile for weight (only 1 of the 17 had been over the 75th centile at birth). The control group, on the other hand, only rose from an average of 35 at birth to 50 over an equivalent observation period; this was significantly lower than the treated group. After folate supplementation had stopped 7 of the 17 treated infants maintained the rating they had reached, but 10 declined and 5 of these, seen towards the end of the first year, had fallen below their birth centile for weight. The control group, of which 27 were seen at the end of the first year, had a similar proportion of infants who dropped below their weight centiles at birth (9 of 27). Thus by the end of the year only a slight difference in the distribution of weight centiles could be observed (Figs. 1, 2) , the effect of folic acid supplementation 6-8 months earlier had almost worn off. (before treatment)
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At 4th m (after treatment) In this study no effect of folate supplementation on Hb levels could be shown (see Table 4 ). Strelling et al. (1966) and Strelling (1973) found low wholeblood folate in some erythroblastotic infants: in 2 (out of a total of 9) who were very severely anaemic, a haematological response was obtained with daily intramuscular folic acid 0 12-0 48 mg. Their rate of weight gain is not referred to. Matoth et al. (1964) reported the results of folic acid supplements on infants with low whole-blood folate due to malnutrition, diarrhoea, and infections, but without macrocytic anaemia, and found no striking haematological response. They stated, 'the effect of folic acid on weight gain was dramatic in some cases'; no further data are given.
It appears that the rate of weight gain of infants short of folic acid and without macrocytic anaemia has not been studied to anyextent. Kendall etal. (1974) gave 50 ,tg folic acid/day by mouth from the second day to the 6th month to a group of infants weighing less than 2 5 kg at birth. By the end of the 6th month their weight was the same as that of the untreated control group. Nevertheless the authors say that 'folate supplements might, however, be necessary in premature infants suffering from a haemolytic anaemia'. Our series of erythroblastotic infants contained only 4 infants in the control group and 2 in the treated group with a birthweight less than 2 5 kg. The treated group were given 2500-5000 ,ug/d and there was a definite effect on the weight centiles at the end of supplementation. The control group showed only a slight rise in weight centiles which was marginally better than the growth spurt observed by Fizhardinge and Steven (1972a, b) for nonerythroblastotic, small-for-dates babies during the first 6 months. Dallman (1974) gave intramuscular folic acid, 100 ,tg every other day, to preterm infants for 2 weeks. Their serum folate levels rose, but the effect on the rate of weight gain is not reported. The very high levels of serum folate in all our samples obtained from treated infants indicates that absorption of folate from the intestinal mucosa was not a problem. This is in full agreement with the findings of Samuel et al. (1973) .
The question arises as to whether there are any possible long-term effects of a low average centile for weight in a group of infants who are not anaemic, but have a low serum folate. At first sight it appears to be reasonable to assume that erythroblastotic infants have managed to develop fairly normally during the last 20 years without a folate supplement. Walker et al. (1974) have published a most careful follow-up study of survivors of Rh-haemolytic disease. Among these children they found the following abnormalities at 7-14 years of age: mild sensoryneural hearing loss in 57 of 260 children (those with kernicterus being excluded), and mild or moderate handicap in language attainment in 43 of 255 children. The authors say, 'it is possible that factors unrelated to events in the neonatal period are involved and may account for the fact that 100 children in this study had impaired reading attainment . . Fitzhardinge and Steven (1972a, b) found among 8-year-old children who had been small-for-dates infants a prevalence of defective language attainment and poor school performance (the latter in 50% of the boys and 36 % of the girls). The role of a shortage of folic acid during the first year of life-a period so important for the biosynthesis of myelin -is not referred to.
The adverse effect of severe maternal folate deficiency on the motor and mental development of infants and children has been reported by Gross et al. (1974) . They found 8 of 14 such children affected, and Arakawa et al. (1969 and 1970) had come to similar conclusions. The effect of low serum folate levels on the central nervous system in adults has been reviewed recently by Melamed et al. (1975 
